Author(s): Yates CM, Calder PC, Ed Rainger G
Omega-3 (n-3) polyunsaturated fatty acids (n-3 PUFAs) have well documented anti-inflammatory properties, and consequently therapeutic potential in chronic inflammatory diseases. Here we discuss the effects of n-3 PUFAs on various inflammatory pathways and how this leads to alterations in the function of inflammatory cells, most importantly endothelial cells and leukocytes. Strong evidence indicates n-3 PUFAs are beneficial as a dietary supplement in certain diseases such as rheumatoid arthritis; however for other conditions such as asthma, the data are less robust. A clearer understanding of the pharmacology of n-3 PUFAs will help to establish targets to modulate chronic inflammatory diseases.
Referred From: https://www.ncbi.nlm.nih.gov/pubmed/24201219
Author(s): Hassan-Smith G, Douglas MR
Author(s): Río J, Comabella M, Montalban X
Author(s): Yadav V, Shinto L, Bourdette D
Author(s): Leong EM, Semple SJ, Angley M, Siebert W, Petkov J, et al.
Author(s): Marrie RA, Hadjimichael O, Vollmer T
Author(s): Schwarz S, Knorr C, Geiger H, Flachenecker P
Author(s): Shinto L, Calabrese C, Morris C, Yadav V, Griffith D, et al.
Author(s): Rezapour-Firouzi S, Arefhosseini SR, Mehdi F, Mehrangiz EM, Baradaran B, et al.
Author(s): vonGeldern G, Mowry EM
Author(s): Fetterman JW Jr, Zdanowicz MM
Author(s): Lands WE
Author(s): Calder PC
Author(s): Burdge GC, Calder PC
Author(s): Calder PC
Author(s): Gorjão R, Azevedo-Martins AK, Rodrigues HG, Abdulkader F, Arcisio-Miranda M, et al.
Author(s): Iwami D, Nonomura K, Shirasugi N, Niimi M
Author(s): Bates D, Cartlidge NE, French JM, Jackson MJ, Nightingale S, et al.
Author(s): Gallai V, Sarchielli P, Trequattrini A, Franceschini M, Floridi A, et al.
Author(s): Neu I, Mallinger J, Wildfeuer A, Mehlber L
Author(s): Weinstock-Guttman B, Baier M, Park Y, Feichter J, Lee-Kwen P, et al.
Author(s): Sierra S, Lara-Villoslada F, Comalada M, Olivares M, Xaus J
Author(s): Verlengia R, Gorjão R, Kanunfre CC, Bordin S, Martins De Lima T, et al.